People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
Marta Figueiredo, PhD
Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo, PhD
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to XTMAB-16, Xentria’s investigational…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
Testicular sperm aspiration for in vitro fertilization (IVF) is a successful strategy to overcome infertility associated with…
Severe fatigue affects more than 60% of pulmonary sarcoidosis patients and is associated with worse shortness of breath,…
Intermediate monocytes, a type of immune cell, may contribute to the development and progression of sarcoidosis through the production of…
Transbronchial Lung Cryobiopsy Helps Provide Definitive Diagnose of Sarcoidosis, Study Suggests
Transbronchial lung cryobiopsy — a relatively new method of collecting lung tissue for analysis — safely and successfully helps…
Researchers have reported a new case of cutaneous sarcoidosis in a Finnish woman previously treated for Hodgkin’s lymphoma —…
The occurrence of sarcoidosis and sarcoma — a rare type of cancer — at the same time or…
Sarcoidosis patients can be divided into women over age 40 with skin and eye lesions, and men under 40…